Suchergebnisse - "Gaylis, Norman"

PubPharm (65)

1

Understanding immune dysregulation in post-acute sequelae of COVID-19 (PASC)-The hunt for effective treatments

enthalten in: The Journal of infection | 2024

von Gaylis, N. | Yang, O.

2

'Totality of Evidence' Approach in the Development of GP2017, an Approved Adalimumab Biosimilar

enthalten in: Advances in therapy | 2024

von Gaylis, N. | Both, C. | Lemke, L. | +2

3

‘Totality of Evidence’ Approach in the Development of GP2017, an Approved Adalimumab Biosimilar

enthalten in: Advances in therapy | 2024

von Gaylis, N. | Both, C. | Lemke, L. | +2

4

A plain language summary describing how two different concentrations of GP2017, a biosimilar adalimumab medicine, are associated with similar drug levels within the body

enthalten in: Immunotherapy | 2023

von Danese, S. | Wiland, P. | Cohen, R. | +6

5

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Recknor, C. | Hansen, S. | Gaylis, N. | +3

CommentOn: Clin Infect Dis. 2022 Oct 12;75(8):1485-1486. - PMID 35819236

6

Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Gaylis, N. | Ritter, A. | Kelly, S. | +6

CommentIn: Clin Infect Dis. 2022 Oct 12;75(8):1485-1486. - PMID 35819236

7

Considering Immuno-autonomics in Stratifying Successful Treatment of Rheumatoid Arthritis with Tumor Necrosis Factor Inhibition : Comment on Cohen et al. Rheumatol Ther 2021 June 19

enthalten in: Rheumatology and therapy | 2022

von Holman, A. | Keystone, E. | Choy, E. | +3

8

The results of a unique dietary supplement (nutraceutical formulation) used to treat the symptoms of long-haul COVID

enthalten in: Frontiers in nutrition | 2022

von Gaylis, N. | Kreychman, I. | Sagliani, J. | +2

9

Considering Immuno-autonomics in Stratifying Successful Treatment of Rheumatoid Arthritis with Tumor Necrosis Factor Inhibition: Comment on Cohen et al. Rheumatol Ther 2021 June 19

enthalten in: Rheumatology and therapy | 2021

von Holman, A. | Keystone, E. | Choy, E. | +3

10

Considering Immuno-autonomics in Stratifying Successful Treatment of Rheumatoid Arthritis with Tumor Necrosis Factor Inhibition: Comment on Cohen et al. Rheumatol Ther 2021 June 19

enthalten in: Rheumatology and therapy | 2021

von Holman, A. | Keystone, E. | Choy, E. | +3

1
2
3
4
5
6
7
Nächster »
[7]